169 related articles for article (PubMed ID: 36379375)
1. Concurrent pulmonary Aspergillus and non-Aspergillus mold infections in allogeneic hematopoetic cell transplant recipients.
Gali V; Kaltsas A; Cintrón M; Papanicolaou GA; Lee YJ
Transpl Immunol; 2023 Feb; 76():101745. PubMed ID: 36379375
[TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.
Hill JA; Dalai SC; Hong DK; Ahmed AA; Ho C; Hollemon D; Blair L; Maalouf J; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE
Clin Infect Dis; 2021 Dec; 73(11):e3876-e3883. PubMed ID: 33119063
[TBL] [Abstract][Full Text] [Related]
3. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
[TBL] [Abstract][Full Text] [Related]
4. Serial Quantitation of Plasma Microbial Cell-Free DNA Before and After Diagnosis of Pulmonary Invasive Mold Infections After Hematopoietic Cell Transplant.
Heldman MR; Ahmed AA; Liu W; Vo A; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE; Hill JA
J Infect Dis; 2024 Feb; 229(2):576-587. PubMed ID: 37405403
[TBL] [Abstract][Full Text] [Related]
5. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.
Herity LB; Cruz OA; Aziz MT
J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508
[TBL] [Abstract][Full Text] [Related]
7. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
Park BJ; Pappas PG; Wannemuehler KA; Alexander BD; Anaissie EJ; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt L; Ito JI; Kauffman CA; Lyon GM; Marr KA; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wingard JR; Walsh TJ; Kontoyiannis DP
Emerg Infect Dis; 2011 Oct; 17(10):1855-64. PubMed ID: 22000355
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.
Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Solé J; Gavaldá J; Roman A
Transpl Infect Dis; 2016 Feb; 18(1):70-8. PubMed ID: 26678668
[TBL] [Abstract][Full Text] [Related]
9. Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
Fontana L; Perlin DS; Zhao Y; Noble BN; Lewis JS; Strasfeld L; Hakki M
Clin Infect Dis; 2020 Feb; 70(5):723-730. PubMed ID: 30958538
[TBL] [Abstract][Full Text] [Related]
10. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
[TBL] [Abstract][Full Text] [Related]
13. Antifungal prophylaxis in haematology patients: the role of voriconazole.
Hicheri Y; Cook G; Cordonnier C
Clin Microbiol Infect; 2012 Apr; 18 Suppl 2():1-15. PubMed ID: 22409648
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.
Mendoza MA; Anderson A; Morris MI; Lekakis L; Simkins J; Prado CE; Martinez OV; Komanduri KV; Camargo JF
Mycopathologia; 2020 Apr; 185(2):399-403. PubMed ID: 31925638
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
[TBL] [Abstract][Full Text] [Related]
16. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
Tamura K; Drew R
Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole in the treatment of invasive mold infections in transplant recipients.
Fortún J; Martín-Dávila P; Sánchez MA; Pintado V; Alvarez ME; Sánchez-Sousa A; Moreno S
Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):408-13. PubMed ID: 12827536
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
Bogler Y; Stern A; Su Y; Lee YJ; Seo SK; Shaffer B; Perales MA; Papanicolaou GA; Neofytos D
Med Mycol; 2021 Oct; 59(10):970-979. PubMed ID: 34036319
[TBL] [Abstract][Full Text] [Related]
19. Practical issues related to non-Aspergillus invasive mold infections.
Nucci M; Nouér SA
Mol Aspects Med; 2023 Dec; 94():101230. PubMed ID: 38011770
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
